Detalles de la búsqueda
1.
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Ann Hematol;
101(6): 1227-1237, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380239
2.
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Hematol Oncol;
38(5): 754-762, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32950042
3.
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy.
Hematol Oncol;
37(4): 447-455, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385337
4.
Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience.
Cancers (Basel);
14(19)2022 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230640
5.
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL).
J Geriatr Oncol;
12(4): 550-556, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097455
6.
Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome.
Leuk Lymphoma;
60(12): 3044-3050, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31120311
7.
Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study.
Hemasphere;
3(6): e320, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31976489
Resultados
1 -
7
de 7
1
Próxima >
>>